Testimonials and Navigation in Rheumatology

Recruiting now · Not applicable

Conditions studied: Rheumatologic Disease, Autoimmune Diseases

In brief

The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.

Key facts

Study ID

NCT06469788

Run by

University of Alabama at Birmingham

People needed

1170

Starts

2024-12-18

Expected to finish

2028-05-31

Last updated by the study team

2026-05-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (18+ years) with known AIRD
• Black race and/or Latinx ethnicity
• Individuals who have not obtained the updated COVID-19 vaccine series (self-report)

You may not qualify if…

• Lack of access to phone

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States (enrolling)
• Brigham Women's Hospital — Boston, Massachusetts, United States
• University of Massachusetts Chan Medical School — Worcester, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.